High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease

Kidney International

Volumn 88, Issue 1, 2015, Pages 130-136

  Bolignano, Davide ^a,b   Lennartz, Simone ^b   Leonardis, Daniela ^a   D'Arrigo, Graziella ^a   Tripepi, Rocco ^a   Emrich, Insa E ^b   Mallamaci, Francesca ^a   Fliser, Danilo ^b   Heine, Gunnar ^b   Zoccali, Carmine ^a  

^a CNR   (Italy)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Cardiovascular death; Cardiovascular events; Chronic kidney disease; Pulmonary hypertension

Indexed keywords

ACUTE HEART FAILURE; ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH ESTIMATED PULMONARY ARTERY SYSTOLIC PRESSURE; HUMAN; LEFT ATRIAL DIAMETER; LEFT ATRIAL VOLUME INDEXED BY BODY SURFACE AREA; LEFT VENTRICULAR MASS INDEXED BY BODY SURFACE AREA; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HEART ATRIUM; MORTALITY; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PULMONARY ARTERY; RENAL INSUFFICIENCY; SYSTOLE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PULMONARY ARTERY; RENAL INSUFFICIENCY; SYSTOLE;

EID: 84934435971     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.27     Document Type: Article

References (31)

1. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004; 351: 1344-1346.
2. Tonelli M, Muntner P, Lloyd A et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a populationlevel cohort study. Lancet 2012; 380: 807-814.
3. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006; 70: 26-33.
4. Paoletti E, Bellino D, Gallina AM et al. Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease? Nephrol Dial Transplant 2011; 26: 670-677.
5. Hyduk A, Croft JB, Ayala C et al. Pulmonary hypertension surveillance-United States, 1980-2002. MMWR Surveill Summ 2005; 54: 1-28.
6. George MG, Schieb LJ, Ayala C et al. Pulmonary hypertension surveillance-United States, 2001-2010. Chest 2014; 146: 476-495.
7. Bolignano D, Rastelli S, Agarwal R et al. Pulmonary hypertension in CKD. Am J Kidney Dis 2013; 61: 612-622.
8. Yang QM, Bao XR. Pulmonary hypertension in patients with stage 1-3 chronic kidney disease. Genet Mol Res 2014; 13: 5695-5703.
9. Abdelwhab S, Elshinnawy S. Pulmonary hypertension in chronic renal failure patients. Am J Nephrol 2008; 28: 990-997.
10. Havlucu Y, Kursat S, Ekmekci C et al. Pulmonary hypertension in patients with chronic renal failure. Respiration 2007; 74: 503-510.
11. Lam CS, Borlaug BA, Kane GC et al. Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 2009; 119: 2663-2670.
12. Strange G, Playford D, Stewart S et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 2012; 98: 1805-1811.
13. Simonneau G, Robbins IM, Beghetti M et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: S43-S54.
14. Kielstein JT, Bode-Boger SM, Hesse G et al. Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 2005; 25: 1414-1418.
15. Velez-Roa S, Ciarka A, Najem B et al. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 2004; 110: 1308-1312.
16. Taal MW. Arterial stiffness in chronic kidney disease: an update. Curr Opin Nephrol Hypertens 2014; 23: 169-173.
17. Ghio S, Gavazzi A, Campana C et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001; 37: 183-188.
18. Li Z, Liu S, Liang X et al. Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients. Int Urol Nephrol 2014; 46: 141-149.
19. Unal A, Sipahioglu M, Oguz F et al. Pulmonary hypertension in peritoneal dialysis patients: prevalence and risk factors. Perit Dial Int 2009; 29: 191-198.
20. Agarwal R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transplant 2012; 27: 3908-3914.
21. Pabst S, Hammerstingl C, Hundt F et al. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study. PLoS One 2012; 7: e35310.
22. Paoletti E, Zoccali C. A look at the upper heart chamber: the left atrium in chronic kidney disease. Nephrol Dial Transplant 2014; 29: 1847-1853.
23. Yigla M, Fruchter O, Aharonson D et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int 2009; 75: 969-975.
24. Galie N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.
25. Seiler S, Rogacev KS, Roth HJ et al. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4. Clin J Am Soc Nephrol 2014; 9: 1049-1058.
26. Zoccali C, Leonardis D, Enia G et al. MAURO study working group. The MAURO study: multiple intervention and audit in renal diseases to optimize care. J Nephrol 2008; 21: 20-22.
27. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
28. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
29. Teichholz LE, Kreulen T, Herman MV et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7-11.
30. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
31. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70: 657-662.